AlphaGrep UK Ltd’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$260K Sell
1,065
-497
-32% -$116K 0.08% 580
2025
Q4
$323K Buy
+1,562
New +$309K 0.11% 380

Other funds holding JNJ

AlphaGrep UK Ltd's JNJ Position: Q1 2026 in Review

AlphaGrep UK Ltd reduced its Johnson & Johnson (JNJ) stake by 32% in Q1 2026, selling an estimated $116K and leaving 1,065 shares worth $260K. The position accounts for 0.08% of the portfolio, ranked #580.

AlphaGrep UK Ltd first reported a position in JNJ in Q4 2025 and has held it in 2 quarters since. The position peaked at $323K in Q4 2025. 4,634 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • AlphaGrep UK Ltd held 1,065 shares of Johnson & Johnson worth $260K as of Q1 2026.
  • AlphaGrep UK Ltd sold 497 Johnson & Johnson shares in Q1 2026, an estimated $116K.
  • Johnson & Johnson made up 0.08% of AlphaGrep UK Ltd's portfolio in Q1 2026, its #580 holding.
  • AlphaGrep UK Ltd first reported a position in Johnson & Johnson in Q4 2025 and has held it in 2 quarters since.
  • AlphaGrep UK Ltd's Johnson & Johnson position peaked at $323K in Q4 2025.
  • 4,634 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.